Home/Filings/4/0001104659-20-027392
4//SEC Filing

Frost Ronald 4

Accession 0001104659-20-027392

CIK 0000856982other

Filed

Feb 27, 7:00 PM ET

Accepted

Feb 28, 9:28 PM ET

Size

18.4 KB

Accession

0001104659-20-027392

Insider Transaction Report

Form 4
Period: 2020-02-26
Frost Ronald
Chief Operating Officer
Transactions
  • Award

    Non-qualified stock options (right to buy)

    2020-02-26+16,72216,722 total
    Exercise: $37.71From: 2021-02-26Exp: 2027-02-26Common Stock (16,722 underlying)
  • Award

    Performance Stock Units

    2020-02-26+7,9557,955 total
    From: 2021-03-15Exp: 2023-03-15Common Stock (7,955 underlying)
Holdings
  • Common Stock, No Par Value

    (indirect: By 401(k))
    16,311
  • Common Stock, No Par Value

    5,000
  • Non-qualified stock options (right to buy)

    Exercise: $12.06From: 2015-10-04Exp: 2021-10-04Common Stock (25,000 underlying)
    25,000
  • Non-qualified stock options (right to buy)

    Exercise: $17.27From: 2016-02-13Exp: 2022-02-13Common Stock (20,000 underlying)
    20,000
  • Non-qualified stock options (right to buy)

    Exercise: $16.05From: 2017-01-28Exp: 2023-01-28Common Stock (20,000 underlying)
    20,000
  • Non-qualified stock options (right to buy)

    Exercise: $28.20From: 2018-04-14Exp: 2024-04-14Common Stock (50,000 underlying)
    50,000
  • Non-qualified stock options (right to buy)

    Exercise: $44.80From: 2019-03-02Exp: 2025-03-02Common Stock (40,000 underlying)
    40,000
  • Non-qualified stock options (right to buy)

    Exercise: $55.73From: 2020-03-01Exp: 2026-03-01Common Stock (30,000 underlying)
    30,000
Footnotes (11)
  • [F1]Represents plan holdings as of 02/26/2020.
  • [F10]On February 26, 2020, the reporting person was awarded a target number of performance share units ("PSUs") pursuant to a Performance Stock Unit Award Agreement by and between the Reporting Person and the Issuer. The actual number of PSUs to be awarded to the Reporting Person will be based upon the Issuer's free cash flow measured against its 2020 financial plan over one, two and three-year periods ending December 31, 2020, 2021 and 2022, respectively, and subject to the Reporting Person's continued employment with the Issuer and the conditions set forth in the Stock Unit Award Agreement.
  • [F11]If earned by the Reporting Person, the PSUs will be awarded not later than March 15 of the year following the Issuer's achievement of the target level of free cash flow, subject to conditions set forth in the Performance Stock Unit Award Agreement.
  • [F2]Become exercisable in equal annual installments of 20% commencing 10/04/2015.
  • [F3]Become exercisable in equal annual installments of 20% commencing 02/13/2016.
  • [F4]Become exercisable in equal annual installments of 20% commencing 01/28/2017.
  • [F5]Become exercisable in equal annual installments of 20% commencing 04/14/2018.
  • [F6]Become exercisable in equal annual installments of 20% commencing 03/02/2019.
  • [F7]Become exercisable in equal annual installments of 20% commencing 03/01/2020.
  • [F8]Become exercisable in equal annual installments of 25% commencing 02/26/2021.
  • [F9]Each performance share unit represents the Company's commitment to issue one share of Merit Medical Systems, Inc. common stock, subject to achievement of performance criteria.

Documents

1 file

Issuer

MERIT MEDICAL SYSTEMS INC

CIK 0000856982

Entity typeother

Related Parties

1
  • filerCIK 0001595939

Filing Metadata

Form type
4
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 9:28 PM ET
Size
18.4 KB